{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:12:08Z","timestamp":1790208728035,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI061085"],"award-info":[{"award-number":["PI061085"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PS0901900"],"award-info":[{"award-number":["PS0901900"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI12\/00192"],"award-info":[{"award-number":["PI12\/00192"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/01722"],"award-info":[{"award-number":["PI13\/01722"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00689"],"award-info":[{"award-number":["PI16\/00689"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00927"],"award-info":[{"award-number":["PI19\/00927"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["S2010\/BMD- 2308"],"award-info":[{"award-number":["S2010\/BMD- 2308"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Each year, more than two million babies die or evolve to permanent invalidating sequelae worldwide because of Hypoxic-Ischemic Brain Injury (HIBI). There is no current treatment for that condition except for therapeutic hypothermia, which benefits only a select group of newborns. Preclinical studies offer solid evidence of the neuroprotective effects of Cannabidiol (CBD) when administered after diffuse or focal HI insults to newborn pigs and rodents. Such effects are observable in the short and long term as demonstrated by functional, neuroimaging, histologic and biochemical studies, and are related to the modulation of excitotoxicity, inflammation and oxidative stress\u2014the major components of HIBI pathophysiology. CBD protects neuronal and glial cells, with a remarkable effect on preserving normal myelinogenesis. From a translational point of view CBD is a valuable tool for HIBI management since it is safe and effective. It is administered by the parenteral route <jats:italic>a posteriori<\/jats:italic> with a broad therapeutic time window. Those findings consolidate CBD as a promising treatment for neonatal HIBI, which is to be demonstrated in clinical trials currently in progress.<\/jats:p>","DOI":"10.3389\/fphar.2020.584533","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T01:20:02Z","timestamp":1610500802000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury"],"prefix":"10.3389","volume":"11","author":[{"given":"Jos\u00e9","family":"Mart\u00ednez-Orgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aar\u00f3n","family":"del Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1212\/CPJ.0000000000000077","article-title":"Diagnosis and acute management of perinatal arterial ischemic stroke","volume":"4","author":"Armstrong-Wells","year":"2014","journal-title":"Neurol. Clin. Pract."},{"key":"B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/pr.2017.104","article-title":"Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets","volume":"82","author":"Arruza","year":"2017","journal-title":"Pediatr. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1523\/JNEUROSCI.22-02-00455.2002","article-title":"Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia","volume":"22","author":"Back","year":"2002","journal-title":"J. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.11.020","article-title":"Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage","volume":"146","author":"Barata","year":"2019","journal-title":"Neuropharmacology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/187152411796011303","article-title":"Astrocytes: targets for neuroprotection in stroke","volume":"11","author":"Barreto","year":"2011","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphar.2017.00269","article-title":"Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders","volume":"8","author":"Campos","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neuropharm.2016.12.017","article-title":"Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke","volume":"116","author":"Cepri\u00e1n","year":"2017","journal-title":"Neuropharmacology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3389\/fphar.2019.01131","article-title":"Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats","volume":"10","author":"Cepri\u00e1n","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neulet.2014.01.014","article-title":"Astrogliosis as a therapeutic target for neurodegenerative diseases","volume":"565","author":"Colangelo","year":"2014","journal-title":"Neurosci. Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijdevneu.2015.06.008","article-title":"Neuronal death after perinatal cerebral hypoxia-ischemia: focus on autophagy-mediated cell death","volume":"45","author":"Descloux","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/1871527311312030007","article-title":"Age-dependent microglial activation in immature brains after hypoxia- ischemia","volume":"12","author":"Ferrazzano","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuropharm.2019.02.004","article-title":"Increased expression of cannabinoid CB2 and serotonin 5-HT1A heteroreceptor complexes in a model of newborn hypoxic-ischemic brain damage","volume":"152","author":"Franco","year":"2019","journal-title":"Neuropharmacology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrn.2016.51","article-title":"Autophagy in acute brain injury","volume":"17","author":"Galluzzi","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/pr.2016.149","article-title":"Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets","volume":"80","author":"Garberg","year":"2016","journal-title":"Pediatr. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pharmthera.2008.07.003","article-title":"Therapeutics for neonatal brain injury","volume":"120","author":"Gonzalez","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/STROKEAHA.111.000104","article-title":"Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke","volume":"44","author":"Gonzalez","year":"2013","journal-title":"Stroke"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1177\/0883073811408092","article-title":"Hypothermia is correlated with seizure absence in perinatal stroke","volume":"26","author":"Harbert","year":"2011","journal-title":"J. Child Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S1474-4422(11)70016-3","article-title":"Treatment advances in neonatal neuroprotection and neurointensive care","volume":"10","author":"Johnston","year":"2011","journal-title":"Lancet Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.clp.2013.09.004","article-title":"Pharmacologic neuroprotective strategies in neonatal brain injury","volume":"41","author":"Juul","year":"2014","journal-title":"Clin. Perinatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fnins.2014.00359","article-title":"Barrier mechanisms in neonatal stroke","volume":"8","author":"Kratzer","year":"2014","journal-title":"Front. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1203\/PDR.0b013e3182276b11","article-title":"Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs","volume":"70","author":"Lafuente","year":"2011","journal-title":"Pediatr. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fnins.2016.00323","article-title":"Effects of cannabidiol and hypothermia on short-term brain damage in new-born piglets after acute hypoxia-ischemia","volume":"10","author":"Lafuente","year":"2016","journal-title":"Front. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jama.2017.14972","article-title":"Effect of therapeutic hypothermia initiated after 6 hours of age on death or disability among newborns with hypoxic-ischemic encephalopathy a randomized clinical trial","volume":"318","author":"Laptook","year":"2017","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/dmcn.12972","article-title":"Prognostic factors for cerebral palsy and motor impairment in children born very preterm or very low birthweight: a systematic review","volume":"58","author":"Linsell","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/pr.2013.188","article-title":"Astrocytes and microglia in acute cerebral injury underlying cerebral palsy associated with preterm birth","volume":"75","author":"Mallard","year":"2014","journal-title":"Pediatr. Res."},{"key":"B30","first-page":"85","article-title":"Estrategias de neuroprotecci\u00f3n en el reci\u00e9n nacido","volume":"12","author":"Mart\u00ednez-Orgado","year":"2014","journal-title":"An Pediatr Contin"},{"key":"B31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/157488907780832724","article-title":"The seek of neuroprotection: introducing cannabinoids","volume":"2","author":"Mart\u00ednez-Orgado","year":"2007","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol--recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem. Biodivers."},{"key":"B33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/1871527315666160927110305","article-title":"Neuroprotective effects of cannabidiol in hypoxic ischemic insult. The therapeutic window in newborn mice","volume":"16","author":"Mohammed","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1053\/j.semperi.2016.09.007","article-title":"Outcomes in childhood following therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy (HIE)","volume":"40","author":"Natarajan","year":"2016","journal-title":"Semin. Perinatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/GRF.0b013e318187087c","article-title":"Causative factors in cerebral palsy","volume":"51","author":"Nelson","year":"2008","journal-title":"Clin. Obstet. Gynecol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jpeds.2017.08.031","article-title":"Neuroprotective strategies in neonatal brain injury","volume":"192","author":"Parikh","year":"2018","journal-title":"J. Pediatr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"B39","first-page":"32","article-title":"The pharmacology and therapeutic potential of cannabidiol","volume-title":"Cannabinoids","author":"Pertwee","year":"2004"},{"key":"B40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.clp.2016.04.002","article-title":"Pathophysiology of birth asphyxia","volume":"43","author":"Rainaldi","year":"2016","journal-title":"Clin. Perinatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4901014","article-title":"Plasticity in the neonatal brain following hypoxic-ischaemic injury","volume":"2016","author":"Rocha-Ferreira","year":"2016","journal-title":"Neural Plast."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pneurobio.2004.02.001","article-title":"Astrocyte apoptosis: implications for neuroprotection","volume":"72","author":"Takuma","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1203\/PDR.0b013e3181fcb40b","article-title":"Melatonin promotes myelination by decreasing white matter inflammation after neonatal stroke","volume":"69","author":"Villapol","year":"2011","journal-title":"Pediatr. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ijdevneu.2011.02.012","article-title":"The developing oligodendrocyte: key cellular target in brain injury in the premature infant","volume":"29","author":"Volpe","year":"2010","journal-title":"Int. J. Dev. Neurosci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.584533\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T21:10:57Z","timestamp":1610572257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.584533\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":45,"alternative-id":["10.3389\/fphar.2020.584533"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.584533","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"article-number":"584533"}}